N/A
N=105
Ultra Low Dose CT for CACS and AC of SPECT
Coronary Artery Disease
Bottom Line
View on ClinicalTrials.gov: NCT02458352 ↗Enrolled (actual)
105
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcome: Primary: Agreement and Correlation of Coronary Artery Calcium Score Obtained From Ultra-low-dose and Standard CT — 212; 178 Agatston score
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Ultra low dose non-contrast enhanced CT (Device); Standard dose non-contrast enhanced CT (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Zurich
- Primary completion
- Oct 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Agreement and Correlation of Coronary Artery Calcium Score Obtained From Ultra-low-dose and Standard CT |
212; 178 | — |
| PRIMARY Intra-class Correlation Coefficient Between Segmental Relative Tracer Uptake From SPECT Datasets Reconstructed With AC Maps Based on Ultra-Low-Dose and Standard Dose CT |
1; 0.987 | — |
Summary
The aim of the study is to compare the CACS obtained from standard dose CT to the CACS obtained from ultra-low-dose scans. Additionally, the usefulness of ultra-low-dose CT for AC of myocardial perfusion SPECT will be assessed.
Eligibility Criteria
Inclusion Criteria
- Patients referred for myocardial perfusion SPECT
- Male and Female subjects ≥18 years of age,
- Written informed consent
Exclusion Criteria
- Pregnancy or breast-feeding
- CACS of 0 after inclusion of 10 patients with CACS 0
- Stents or implanted cardiac devices (valves, pace makers, ICD)
- Coronary artery bypass grafts
Data sourced from ClinicalTrials.gov (NCT02458352). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.